A technician in a clinic performs a CLIA-waived rapid strep test on a throat swab and a fingerstick glucose, with control solutions and log sheets ready. Morning controls have not been run. Which point-of-care testing and quality-control action should the technician take for valid waived results?

Valid waived testing still requires quality control exactly as the manufacturer and laboratory procedure direct, performed for each test system, with results documented and acceptable before any patient specimen is tested or reported, which is why running and documenting expected controls first is required to ensure reagents, technique, and instruments are performing and to create a traceable record for clinical decisions and inspection. Limiting morning quality control to the strep kit alone fails the per-system requirement because glucose meters are a separate waived system with their own strips and failure modes and cannot be covered by another test's passing controls. Completing controls on time but postponing charting until evening fails the documentation concept because waived compliance depends on contemporaneous logs that prove acceptable performance at the time of testing and prevent retrospective correction or recall confusion. Running patient samples together with controls and reporting conditionally still fails the sequencing concept because patient testing is only valid after controls are already shown to be acceptable, and concurrent work risks erroneous release and inability to contain an out-of-control run. An exam caveat is that waived status never means quality control is optional and built-in procedural lines do not replace required external liquid controls. A practical check is to verify lot numbers and expiration, require controls to be in range, document immediately, and withhold patient reporting if any control fails.